184 related articles for article (PubMed ID: 1683150)
21. Safety of combination therapy with hydroxychloroquine, gold sodium thiomalate and methotrexate in early rheumatoid arthritis.
Biasi D; Caramaschi P; Carletto A; Pacor ML; Bambara LM
Rev Rhum Engl Ed; 1997; 64(7-9):521-2. PubMed ID: 9338941
[No Abstract] [Full Text] [Related]
22. [Combination therapy of rheumatoid arthritis].
Hansen A; Jensen T
Ugeskr Laeger; 1998 Sep; 160(40):5772-6. PubMed ID: 9782754
[TBL] [Abstract][Full Text] [Related]
23. Rheumatoid arthritis V: therapy with remission-inducing agents.
Gaines LM
Md State Med J; 1982 Sep; 31(9):49-50. PubMed ID: 6815385
[No Abstract] [Full Text] [Related]
24. [Duration of use of non-steroidal anti-inflammatory agents in patients with rheumatoid arthritis].
Luggen ME
Rev Rhum Ed Fr; 1994 Dec; 61(10 Pt 2):165S-172S. PubMed ID: 7858568
[TBL] [Abstract][Full Text] [Related]
25. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
[TBL] [Abstract][Full Text] [Related]
26. [Phagocytic activity in rheumatoid arthritis].
Jelcić A; Car A; Gnjidić Z; Sabioncello A
Reumatizam; 1992; 39(2):17-9. PubMed ID: 1366147
[TBL] [Abstract][Full Text] [Related]
27. The effect of antirheumatic drugs on circulating immune complexes in rheumatoid arthritis.
Forster PJ; McConkey B
Q J Med; 1986 Jan; 58(225):29-42. PubMed ID: 2871585
[TBL] [Abstract][Full Text] [Related]
28. Disease-modifying drugs for progressive rheumatoid arthritis.
Bunch TW; O'Duffy JD
Mayo Clin Proc; 1980 Mar; 55(3):161-79. PubMed ID: 6766523
[TBL] [Abstract][Full Text] [Related]
29. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori.
Rybár I; Masaryk P; Mateicka F; Kopecký S; Rovenský J
Int J Clin Pharmacol Res; 2001; 21(3-4):119-25. PubMed ID: 12067141
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol.
Quinn MA; Green MJ; Marzo-Ortega H; Proudman S; Karim Z; Wakefield RJ; Conaghan PG; Emery P
Arthritis Rheum; 2003 Nov; 48(11):3039-45. PubMed ID: 14613264
[TBL] [Abstract][Full Text] [Related]
31. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.
Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110
[TBL] [Abstract][Full Text] [Related]
32. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
Wolfe F; Anderson J; Burke TA; Arguelles LM; Pettitt D
J Rheumatol; 2002 Mar; 29(3):467-73. PubMed ID: 11908558
[TBL] [Abstract][Full Text] [Related]
33. [Medical treatment of rheumatoid arthritis].
Isomäki H; Martio J
Duodecim; 1976; 92(6):304-12. PubMed ID: 816634
[No Abstract] [Full Text] [Related]
34. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.
Simon LS
Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314
[TBL] [Abstract][Full Text] [Related]
35. Rheumatologists' adherence to guidelines for misoprostol use in patients at high risk for nonsteroidal antiinflammatory drug gastropathy.
Cibere J; Sibley JT; Haga M
J Rheumatol; 2002 Feb; 29(2):339-46. PubMed ID: 11838854
[TBL] [Abstract][Full Text] [Related]
36. How do French rheumatologists treat early rheumatoid arthritis?
de Asit N; Le Loët X; Czernichow P; Bertho JM; Delcambre B; Tonnel F; Loyau G; Dapogny C; Trèves R; Valat JP; Tauveron P; Sebert JL; Boumier P
Rev Rhum Engl Ed; 1996 Mar; 63(3):188-95. PubMed ID: 8731236
[TBL] [Abstract][Full Text] [Related]
37. Nonsteroidal anti-inflammatory drug use is a significant cause of peptic ulcer disease in a tertiary hospital in Singapore: a prospective study.
Ong TZ; Hawkey CJ; Ho KY
J Clin Gastroenterol; 2006 Oct; 40(9):795-800. PubMed ID: 17016134
[TBL] [Abstract][Full Text] [Related]
38. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use.
Larkai EN; Smith JL; Lidsky MD; Graham DY
Am J Gastroenterol; 1987 Nov; 82(11):1153-8. PubMed ID: 3499815
[TBL] [Abstract][Full Text] [Related]
39. [Gastroduodenal complications associated with non-steroidal anti-inflammatory drugs in Slovak Republic: results of one-year prospective study].
Rybár I; Hlísta M; Masaryk P; Rovenský J; Hyrdel R; Kriska M
Vnitr Lek; 2006; 52(7-8):673-6. PubMed ID: 16967607
[TBL] [Abstract][Full Text] [Related]
40. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients.
Miglioli M; Bianchi Porro G; Vaira D; Menegatti M; Brunetti G; Petrillo M; Ardizzone S; Frizziero L; Montrone F; Grandinetti G
Am J Gastroenterol; 1996 Nov; 91(11):2367-71. PubMed ID: 8931419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
